GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Revenue

ACI Formulations (DHA:ACIFORMULA) Revenue : BDT5,049 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations Revenue?

ACI Formulations's revenue for the three months ended in Dec. 2023 was BDT1,387 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was BDT5,049 Mil. ACI Formulations's Revenue per Share for the three months ended in Dec. 2023 was BDT29.37. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT106.96.

Good Sign:

ACI Formulations Ltd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of ACI Formulations was 7.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 13.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, ACI Formulations's highest 3-Year average Revenue per Share Growth Rate was 16.10% per year. The lowest was -2.40% per year. And the median was 6.80% per year.


ACI Formulations Revenue Historical Data

The historical data trend for ACI Formulations's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations Revenue Chart

ACI Formulations Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,052.37 3,424.04 3,864.53 4,247.42 4,959.81

ACI Formulations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,434.84 1,308.18 923.37 1,430.44 1,387.48

Competitive Comparison of ACI Formulations's Revenue

For the Agricultural Inputs subindustry, ACI Formulations's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACI Formulations's Revenue Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, ACI Formulations's Revenue distribution charts can be found below:

* The bar in red indicates where ACI Formulations's Revenue falls into.



ACI Formulations Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT5,049 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACI Formulations  (DHA:ACIFORMULA) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


ACI Formulations Revenue Related Terms

Thank you for viewing the detailed overview of ACI Formulations's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ACI Formulations (DHA:ACIFORMULA) Business Description

Traded in Other Exchanges
N/A
Address
ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines